1. Home
  2. KURA vs NESR Comparison

KURA vs NESR Comparison

Compare KURA & NESR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KURA
  • NESR
  • Stock Information
  • Founded
  • KURA 2014
  • NESR 2017
  • Country
  • KURA United States
  • NESR United States
  • Employees
  • KURA N/A
  • NESR N/A
  • Industry
  • KURA Biotechnology: Biological Products (No Diagnostic Substances)
  • NESR
  • Sector
  • KURA Health Care
  • NESR
  • Exchange
  • KURA Nasdaq
  • NESR NYSE
  • Market Cap
  • KURA 793.2M
  • NESR 810.3M
  • IPO Year
  • KURA N/A
  • NESR N/A
  • Fundamental
  • Price
  • KURA $9.48
  • NESR $8.53
  • Analyst Decision
  • KURA Strong Buy
  • NESR Strong Buy
  • Analyst Count
  • KURA 10
  • NESR 2
  • Target Price
  • KURA $30.13
  • NESR $14.00
  • AVG Volume (30 Days)
  • KURA 2.9M
  • NESR 147.1K
  • Earning Date
  • KURA 11-07-2024
  • NESR 11-19-2024
  • Dividend Yield
  • KURA N/A
  • NESR N/A
  • EPS Growth
  • KURA N/A
  • NESR N/A
  • EPS
  • KURA N/A
  • NESR 0.54
  • Revenue
  • KURA N/A
  • NESR $1,265,542,000.00
  • Revenue This Year
  • KURA N/A
  • NESR $13.71
  • Revenue Next Year
  • KURA $106.66
  • NESR $7.75
  • P/E Ratio
  • KURA N/A
  • NESR $16.03
  • Revenue Growth
  • KURA N/A
  • NESR 39.14
  • 52 Week Low
  • KURA $9.40
  • NESR $7.68
  • 52 Week High
  • KURA $24.17
  • NESR $9.89
  • Technical
  • Relative Strength Index (RSI)
  • KURA 24.01
  • NESR N/A
  • Support Level
  • KURA $9.40
  • NESR N/A
  • Resistance Level
  • KURA $10.02
  • NESR N/A
  • Average True Range (ATR)
  • KURA 0.46
  • NESR 0.00
  • MACD
  • KURA 0.10
  • NESR 0.00
  • Stochastic Oscillator
  • KURA 8.09
  • NESR 0.00

About KURA Kura Oncology Inc.

Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has a product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. Geographically operation of the group is carried through the United States.

About NESR NATIONAL ENERGY SVCS REUNITED CORP

National Energy Services Reunited Corp is a British Virgin Islands-based company engaged in providing products and services to the oil and gas industry in the Middle East and North Africa and the Asia Pacific regions. The company has two reportable segments: Production Services including coil tubing, stimulation, and pumping, nitrogen services, completions, pipelines, cementing, laboratory services and filtration services; and Drilling and Evaluation Services including drilling and workover rigs, rig services, services, and well-testing services among others. Revenues are majorly derived from production services of an oil or natural gas well.

Share on Social Networks: